“BMI and TLC Influences Doxorubicin Epirubicin Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Breast Cancer”. Majalah Kedokteran Bandung, vol. 54, no. 4, Dec. 2022, pp. 221-7, https://doi.org/10.15395/mkb.v54n4.2797.